Wednesday , May 25 2022

The FDA Advisory Committee recommended a booster dose of Johnson & Johnson



[ad_1]

Washington, Oct. 16 – The U.S. Food and Drug Administration (FDA) advisory board on Friday recommended emergency use of a booster dose for the vaccine covid-19 of Johnson & Johnson. The FDA approved a pre-booster dose of covid-19 vaccines from Pfizer and Modern.

All news is only available to subscribers.
The news contains 453 characters (no spaces) or 91 words.

You can buy the news. Price: token 1; on account: 0 tokens

[ad_2]
Source link